Jacqueline
Kosecoff
Director
Dr. Kosecoff, managing partner at Moriah Partners, LLC, and senior advisor at Warburg Pincus, is working in private equity to identify, select, mentor and manage health services and IT companies.
From 2002 to 2012, Dr. Kosecoff was a senior executive inside UnitedHealth Group-PacifiCare. Dr. Kosecoff joined UnitedHealth Group as part of its acquisition of PacifiCare Health Systems in 2005, where she served as executive vice president. Upon joining UnitedHealth Group, Dr. Kosecoff was appointed CEO of Prescription Solutions (now known as OptumRx). Prior to joining UnitedHealth Group-PacifiCare, Dr. Kosecoff was founder, president and chief operating officer of Protocare, a firm whose lines of business included the clinical development of drugs, devices, biopharmaceutical and nutritional products and health services consulting. She also was co-founder and co-CEO of Value Health Sciences (VHS), the first company to combine medical sciences and information technology to reengineer the utilization review and approval process.
Dr. Kosecoff served as professor of medicine and public health at the University of California, Los Angeles from 1975 to 2006. A recognized expert in the areas of clinical and health services research, quality of care and technology assessment, and organization of the health care delivery system, Dr. Kosecoff has published extensively in such journals as The New England Journal of Medicine, Journal of the American Medical Association, and the Annals of Internal Medicine.
She has served as a consultant to the World Health Organization’s Global Quality Assessment Programs, on the Institute of Medicine’s Board of Health Care Services, the RAND Graduate School’s Board of Governors, the Board of Directors for ALARIS (NYSE: AMI), athenahealth, Inc. (NASDAQ: ATHN), CareFusion Corporation (NYSE: CFN), City of Hope (emeritus board member), GoodRx, Inc. (NASDAQ: GDRX), Pharmaceutical Care Management Association (PCMA), Sealed Air Corporation (NYSE: SEE), the Catalyst Western Region Advisory Board, the Alliance for Aging Research, and was a member of the SAP America Executive Advisory Board.
Currently, Dr. Kosecoff sits on the board of directors of these public companies: Alignment Healthcare (NASDAQ: ALHC); Houlihan Lokey (NYSE: HLI); STERIS Corporation (NYSE: STE) and TriNet Group,Inc. (NYSE: TNET), and of these private companies: Alegeus; Independent Living Systems, LLC; InformedDNA; Intelligent Medical Objects (IMO; Iris Telehealth and Maxor.
Dr. Kosecoff holds a Bachelor of Arts from the University of California, Los Angeles (UCLA), a Master of Science in applied mathematics from Brown University, and a doctorate from UCLA.